PORTLAND (AP) — A Maine pharmacy professor is receiving a grant of $375,000 for an early detection innovation in the breast cancer research field.
University of New England College of Pharmacy assistant professor Srinidi Mohan is receiving the grant from the Maine Cancer Foundation.
Mohan received a patent for an early detection, disease monitoring method that uses a marker in the blood to detect the presence of aggressive tumors. The university says Mohan’s innovation can also help track cancer growth.
The university says Mohan discovered the marker while studying nutritional supplements.
Mohan will collaborate with Maine Medical Center Research Institute and a Maine-based company, Maine Biotechnology Services. The grant is a two-year award that will focus on developing a less-invasive indicator for certain kinds of breast tumor prognosis.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less